Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results : (224) Arrow Down
Filter Results : (224) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (894)
    • Faculty Publications  (224)

    Show Results For

    • All HBS Web  (894)
      • Faculty Publications  (224)

      Biotechnology Industry Remove Biotechnology Industry →

      Page 1 of 224 Results →

      Are you looking for?

      Biotechnology Industry Organization (BIO) | Baker Library | Bloomberg Center | Harvard Business School
      × Please sign in You need to log in to use the bookmarking feature. Sign In Using Baker Library During COVID-19 | HBS COVID-19 Business Impact Center...
      Biotechnology Industry Research from Harvard Business School
      Skip to Main Content Cold Call A podcast featuring faculty discussing cases they've written and the lessons they impart. Subscribe on iTunes 29 Sep...
      → Search All HBS Web
      • January 2021
      • Case

      Takeda Pharmaceutical Company Limited (A)

      By: David J. Collis, Nobuo Sato and Akiko Kanno
      This case follows Christophe Weber, President and CEO of Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, as Takeda considers acquiring Shire Plc, a biotech company based in Ireland. The acquisition would turn...  View Details
      Keywords: Pharmaceutical Companies; Pharmaceutical Industry; Pharmaceuticals; Japan; Biotech; biotechnology; M&a; Mergers & Acquisitions; Globalization; Management; Asia; R&d; Talent Management; Mergers And Acquisitions; Globalization; Global Strategy; Pharmaceutical industry; biotechnology industry; Japan
      Citation
      Educators
      Related
      Collis, David J., Nobuo Sato, and Akiko Kanno. "Takeda Pharmaceutical Company Limited (A)." Harvard Business School Case 721-373, January 2021.
      • January 2021
      • Supplement

      Takeda Pharmaceutical Company Limited (B)

      By: David J. Collis, Nobuo Sato and Akiko Kanno
      This case is a follow up to HBS Case No. 721-373, Takeda Pharmaceutical Company Limited (A). Following the events of the previous case, Takeda reached an agreement to acquire Ireland-based Shire Plc. The case follows some of the achievements and challenges Takeda and...  View Details
      Keywords: Pharmaceutical Companies; Pharmaceutical Industry; Pharmaceuticals; M&a; Mergers & Acquisitions; Globalization; Japan; Biotech; biotechnology; R&d; Talent Management; Asia; Strategy; Mergers And Acquisitions; Global Strategy; Strategy; biotechnology industry; Pharmaceutical industry; Japan
      Citation
      Related
      Collis, David J., Nobuo Sato, and Akiko Kanno. "Takeda Pharmaceutical Company Limited (B)." Harvard Business School Supplement 721-374, January 2021.
      • January 2021
      • Case

      Biobot Analytics

      By: Raymond Kluender, Joshua Krieger and Mitchell Weiss
      In 2017, Newsha Ghaeli and Mariana Matus were deciding whether to leave their labs at the Massachusetts Institute of Technology, put other job opportunities aside, and dive full-time into founding a wastewater analysis start-up, Biobot. Ghaeli, an architect, and Matus,...  View Details
      Keywords: Entrepreneurship; Technology; City; Data And Data Sets; Personal Development And Career; Technology industry; Utilities industry; Health industry; Information Technology industry; Information industry; biotechnology industry; United States; Kuwait; Korean Peninsula
      Citation
      Educators
      Related
      Kluender, Raymond, Joshua Krieger, and Mitchell Weiss. "Biobot Analytics." Harvard Business School Case 821-045, January 2021.
      • November 2020
      • Teaching Note

      Valuing Celgene's CVR

      By: Benjamin C. Esty and Daniel Fisher
      When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...  View Details
      Keywords: Mergers And Acquisitions; Valuation; Value; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition And Thinking; Pharmaceutical industry; biotechnology industry; United States
      Citation
      Related
      Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Teaching Note 221-036, November 2020.
      • November 2020
      • Case

      Valuing Celgene's CVR

      By: Benjamin C. Esty and Daniel Fisher
      When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...  View Details
      Keywords: Mergers And Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition And Thinking; Pharmaceutical industry; biotechnology industry; United States
      Citation
      Educators
      Related
      Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
      • November 2020
      • Supplement

      Valuing Celgene's CVR

      By: Benjamin C. Esty and Daniel Fisher
      When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...  View Details
      Keywords: Mergers And Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition And Thinking; Pharmaceutical industry; biotechnology industry; United States
      Citation
      Purchase
      Related
      Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Spreadsheet Supplement 221-705, November 2020.
      • October 2020
      • Case

      When Institutions Fail: HIV/AIDS in the 1980s

      By: Tom Nicholas and Christian Godwin
      During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting...  View Details
      Keywords: Ethics; Policy; Government And Politics; Health; History; Rights; Media; Organizations; Business And Community Relations; Religion; Social Psychology; Identity; Prejudice And Bias; Social Issues; Public Opinion; Pharmaceutical industry; biotechnology industry; Health industry; Journalism And News industry; Media And Broadcasting industry; Public Administration industry; United States
      Citation
      Educators
      Related
      Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020.
      • September 2020 (Revised January 2021)
      • Case

      Catalys Pacific

      By: Joshua Lev Krieger
      In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After...  View Details
      Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-cultural And Cross-border Issues; Pharmaceutical industry; biotechnology industry; Tokyo
      Citation
      Educators
      Purchase
      Related
      Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
      • September 2020
      • Case

      Minerva 2004: Discovery

      By: John R. Wells and Benjamin Weinstock
      After nearly five years in operation, Doctor Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), was reflecting on the company’s next steps. In a few short years, she and her small team had managed to develop a nanoparticle process for...  View Details
      Keywords: Entrepreneurship; Financing And Loans; Strategy; Decision Choices And Conditions; biotechnology industry
      Citation
      Educators
      Purchase
      Related
      Wells, John R., and Benjamin Weinstock. "Minerva 2004: Discovery." Harvard Business School Case 721-389, September 2020.
      • 2020
      • Book

      Work, Mate, Marry, Love: How Machines Shape Our Human Destiny

      By: Debora L. Spar
      Covering a time frame that ranges from 8000 BC to the present, and drawing upon both Marxist and feminist theories, the book argues that nearly all the decisions we make in our most intimate lives—whom to marry, how to have children, how to have sex, how to think about...  View Details
      Keywords: Innovation; Family; Women; Reproduction; Artificial Intelligence; Robots; Gender; Demography; History; Innovation And Invention; Relationships; Society; Technology; biotechnology industry; Computer industry; Health industry; Information Technology industry; Manufacturing industry; Technology industry; Africa; Asia; Europe; Latin America; North And Central America
      Citation
      Purchase
      Related
      Spar, Debora L. Work, Mate, Marry, Love: How Machines Shape Our Human Destiny. New York: Farrar, Straus and Giroux, 2020.
      • June 2020 (Revised March 2020)
      • Case

      Social Salary Setting at Spiber

      By: Ashley Whillans and John Beshears
      Can a “set your own salary” system boost employee happiness and motivation? Spiber made synthetic silk built from proteins mimicking the proteins found in spider silk, the world’s toughest known material by weight. Kazuhide Sekiyama and Junichi Sugahara established...  View Details
      Keywords: Compensation And Benefits; Motivation And Incentives; Happiness; Negotiation Tactics; Cross-cultural And Cross-border Issues; biotechnology industry; Japan; United States
      Citation
      Educators
      Purchase
      Related
      Whillans, Ashley, and John Beshears. "Social Salary Setting at Spiber." Harvard Business School Case 920-050, June 2020. (Revised March 2020.)
      • January 2020
      • Case

      Celata Bioinnovations

      By: John R. Wells and Benjamin Weinstock
      In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process....  View Details
      Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; Fda; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry And Exit; Opportunities; Pharmaceutical industry; biotechnology industry
      Citation
      Educators
      Purchase
      Related
      Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
      • November 2019 (Revised April 2020)
      • Technical Note

      The Life Sciences Revolution: A Technical Primer

      By: Gary P. Pisano, William J. Anderson, Amitabh Chandra, Clarissa Ceruti and Stephanie Oestreich
      For more than two decades, scientific advances have been driving profound changes in drug discovery and the drug industry itself. This case provides an overview and description of these technical and scientific advances. Written for the nonscientific reader, it may be...  View Details
      Keywords: Science; Technological Innovation; Technology; Pharmaceutical industry; biotechnology industry
      Citation
      Educators
      Purchase
      Related
      Pisano, Gary P., William J. Anderson, Amitabh Chandra, Clarissa Ceruti, and Stephanie Oestreich. "The Life Sciences Revolution: A Technical Primer." Harvard Business School Technical Note 620-054, November 2019. (Revised April 2020.)
      • October 2019 (Revised April 2020)
      • Background Note

      Note on Funding Deep Tech Startups

      By: Karim Lakhani, Peter Barrett and Noubar Afeyan
      This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along...  View Details
      Keywords: Entrepreneurship; Energy; Venture Capital; Corporate Finance; Initial Public Offering; Investment; Health Testing And Trials; Innovation And Invention; Technological Innovation; Intellectual Property; Product Design; Product Development; Technology; Research And Development; Risk And Uncertainty; Technology industry; biotechnology industry; United States; North America; Europe; Asia
      Citation
      Educators
      Purchase
      Related
      Lakhani, Karim, Peter Barrett, and Noubar Afeyan. "Note on Funding Deep Tech Startups." Harvard Business School Background Note 620-029, October 2019. (Revised April 2020.)
      • September 2019 (Revised August 2020)
      • Case

      Engineering an Inclusive Bioeconomy

      By: Tarun Khanna, Raffaella Sadun and Susie L. Ma
      In 2019, entrepreneur Juan Carlos Castilla-Rubio was developing a project he hoped could generate and share wealth from the natural resources of the Amazon without destroying those resources. His idea, called Earth Bank of Codes (EBC), would create a library of the...  View Details
      Keywords: Decision Making; Development Economics; Entrepreneurship; Innovation And Invention; Intellectual Property; Emerging Markets; Market Design; Marketplace Matching; Science; Genetics; Natural Environment; Environmental Sustainability; Climate Change; Social Enterprise; Strategy; Strategic Planning; Technology; Ownership; Social Psychology; Trust; Society; biotechnology industry; South America; Amazon Basin
      Citation
      Educators
      Purchase
      Related
      Khanna, Tarun, Raffaella Sadun, and Susie L. Ma. "Engineering an Inclusive Bioeconomy." Harvard Business School Case 720-356, September 2019. (Revised August 2020.)
      • September 2019
      • Case

      Nimbus Therapeutics

      By: Peter Barrett, Karim Lakhani and Julia Kelley
      This case focuses on Nimbus Therapeutics, a biotechnology startup based in Cambridge, Massachusetts, as its leadership team tries to determine the company’s long-term strategy. The startup’s founders structured Nimbus as a limited liability company, which has given it...  View Details
      Keywords: Business Startups; Organizational Structure; Strategy; biotechnology industry
      Citation
      Educators
      Purchase
      Related
      Barrett, Peter, Karim Lakhani, and Julia Kelley. "Nimbus Therapeutics." Harvard Business School Case 620-016, September 2019.
      • September 2019
      • Case

      Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem

      By: Willy C. Shih
      Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine...  View Details
      Keywords: Vaccine; Production; Supply Chain; Product; biotechnology industry; Pharmaceutical industry; Manufacturing industry; Belgium
      Citation
      Educators
      Purchase
      Related
      Shih, Willy C. "Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem." Harvard Business School Case 620-021, September 2019.
      • September 2019
      • Case

      Celgene: Business Development and Distributed Research

      By: Peter Barrett and Kareem Reda
      This case looks at the deal-making process between Celgene, a large publicly traded pharmaceutical company, and Agios, an early-stage biotech company. The framework of a potential deal is explored and the potential road-blocks to Agios’ profitability are discussed. ...  View Details
      Keywords: Negotiation Deal; Alliances; Collaborative Innovation And Invention; Research; Pharmaceutical industry; biotechnology industry
      Citation
      Educators
      Related
      Barrett, Peter, and Kareem Reda. "Celgene: Business Development and Distributed Research." Harvard Business School Case 620-014, September 2019.
      • May 2018
      • Case

      The Multiple Myeloma Research Foundation's Answer Fund

      By: Richard G. Hamermesh and Matthew G. Preble
      Keywords: Data Analytics; Customer Focus And Relationships; Customer Relationship Management; Cost Vs Benefits; Investment Return; Health Care And Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals And Objectives; Marketing Communications; Performance; Programs; Projects; Business And Community Relations; Business And Stakeholder Relations; Networks; Partners And Partnerships; Research And Development; Genetics; Behavior; Motivation And Incentives; Social And Collaborative Networks; Nonprofit Organizations; Strategy; Health industry; Pharmaceutical industry; biotechnology industry; United States
      Citation
      Educators
      Related
      Hamermesh, Richard G., and Matthew G. Preble. "The Multiple Myeloma Research Foundation's Answer Fund." Harvard Business School Case 818-045, May 2018.
      • March 2018 (Revised July 2018)
      • Case

      GreenLight Biosciences: In Search of Impact Investment

      By: Michael Chu, Annelena Lobb and Joni Coughlin
      Greenlight Biosciences, a biotech company, is in search of impact investment for its next round of financing.  View Details
      Keywords: Impact Investment; Investment; Environmental Sustainability; Financing And Loans; biotechnology industry
      Citation
      Educators
      Purchase
      Related
      Chu, Michael, Annelena Lobb, and Joni Coughlin. "GreenLight Biosciences: In Search of Impact Investment." Harvard Business School Case 318-072, March 2018. (Revised July 2018.)
      • 1
      • 2
      • …
      • 11
      • 12
      • →

      Are you looking for?

      Biotechnology Industry Organization (BIO) | Baker Library | Bloomberg Center | Harvard Business School
      × Please sign in You need to log in to use the bookmarking feature. Sign In Using Baker Library During COVID-19 | HBS COVID-19 Business Impact Center...
      Biotechnology Industry Research from Harvard Business School
      Skip to Main Content Cold Call A podcast featuring faculty discussing cases they've written and the lessons they impart. Subscribe on iTunes 29 Sep...
      → Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College